Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: plantone d. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Connick P, De Angelis F, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados Carrasco F, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, Giovannoni G, Gandini Wheeler-Kingshott CA, Hawkins C, Sharrack B, Bastow R, Weir CJ, Stallard N, Chandran S, Chataway J; UK Multiple Sclerosis Society Clinical Trials Network. Connick P, et al. Among authors: plantone d. BMJ Open. 2018 Aug 30;8(8):e021944. doi: 10.1136/bmjopen-2018-021944. BMJ Open. 2018. PMID: 30166303 Free PMC article. Clinical Trial.
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.
John NA, Li Y, De Angelis F, Stutters J, Prados F, Doshi A, Calvi A, Williams T, Plantone D, Phan T, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: plantone d. Eur J Neurol. 2025 Jan;32(1):e16586. doi: 10.1111/ene.16586. Eur J Neurol. 2025. PMID: 39691073 Free PMC article. Clinical Trial.
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.
De Angelis F, Cameron JR, Eshaghi A, Parker R, Connick P, Stutters J, Plantone D, Doshi A, John N, Williams T, Calvi A, MacManus D, Barkhof F, Chandran S, Weir CJ, Toosy A, Chataway J; MS-SMART trial investigators. De Angelis F, et al. Among authors: plantone d. J Neurol Neurosurg Psychiatry. 2024 Dec 18:jnnp-2024-334801. doi: 10.1136/jnnp-2024-334801. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39694820 Free article.
Neurofilament heavy chain in secondary progressive multiple sclerosis.
De Angelis F, Ammoscato F, Parker RA, Plantone D, Doshi A, John NA, Williams T, Stutters J, MacManus D, Schmierer K, Barkhof F, Weir CJ, Giovannoni G, Chataway J, Gnanapavan S. De Angelis F, et al. Among authors: plantone d. Mult Scler. 2025 Jan 22:13524585241311212. doi: 10.1177/13524585241311212. Online ahead of print. Mult Scler. 2025. PMID: 39844621
Neuropsychological tests at the Italian Centers for Cognitive Disorders and Dementias: results from a survey on 450 specialized services.
Vaccaro R, Lorenzini P, Giaquinto F, Matascioli F, Carnevale G, Sciancalepore F, Gasparini M, Salvi E, Corbo M, Locuratolo N, Vanacore N, Bacigalupo I; Permanent Table of the National Dementia Plan Study Group; CCDDs Study Group. Vaccaro R, et al. Aging Clin Exp Res. 2024 Dec 20;37(1):1. doi: 10.1007/s40520-024-02869-6. Aging Clin Exp Res. 2024. PMID: 39704981 Free PMC article.
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.
Ferraro PM, Filippi L, Ponzano M, Signori A, Orso B, Massa F, Arnaldi D, Caneva S, Argenti L, Losa M, Lombardo L, Mattioli P, Costagli M, Gualco L, Pulze M, Plantone D, Brugnolo A, Girtler N, Diociasi A, Garbarino S, Villani F, Sormani MP, Uccelli A, Roccatagliata L, Pardini M; Alzheimer's Disease Neuroimaging Initiative. Ferraro PM, et al. Among authors: plantone d. J Alzheimers Dis. 2025 Jan;103(1):243-255. doi: 10.1177/13872877241299843. Epub 2024 Nov 25. J Alzheimers Dis. 2025. PMID: 39587787
Investigating interleukin-8 in Alzheimer's disease: A comprehensive review.
Righi D, Manco C, Pardini M, Stufano A, Schino V, Pelagotti V, Massa F, Stefano N, Plantone D. Righi D, et al. Among authors: plantone d. J Alzheimers Dis. 2025 Jan;103(1):38-55. doi: 10.1177/13872877241298973. Epub 2024 Nov 18. J Alzheimers Dis. 2025. PMID: 39558604 Review.
Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators.
Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonca A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S. Jessen F, et al. Among authors: plantone d. J Prev Alzheimers Dis. 2024;11(5):1212-1218. doi: 10.14283/jpad.2024.153. J Prev Alzheimers Dis. 2024. PMID: 39350366 Free PMC article.
85 results